(Q46194991)

20 December 2017

title

Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats (English)

1 reference

20 December 2017

experimental autoimmune encephalomyelitis

main subject

1 reference

5

Wahren B

1 reference

20 December 2017

author name string

Zhu J

1

1 reference

20 December 2017

Diab A

2

1 reference

20 December 2017

Mustafa M

3

1 reference

20 December 2017

Levi M

4

1 reference

20 December 2017

Björk J

6

1 reference

20 December 2017

Hedlund G

7

1 reference

20 December 2017

publication date

1 October 1998

1 reference

20 December 2017

Journal of the Neurological Sciences

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

20 December 2017

volume

160

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

113-120

1 reference

20 December 2017

Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Cloning, expression, and purification of rat IFN-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in lewis rats: Dynamics of cellular mrna expression in the central nervous system and lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

The purification and characterization of rat gamma interferon by use of two monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Linomide suppresses both Th1 and Th2 cytokines in experimental autoimmune myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900244-5

10.1016/S0022-510X(98)00244-5

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017